Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular features of intratumoral hemorrhage in glioblastoma isocitrate dehydrogenase-wildtype.

Journal of neuro-oncology - 24 Aug 2026

Bueno Angel, Dono Antonio, Alcantar Oscar, Amezquita-Contreras Christian, Ocasio Laura, Hsu Sigmund, Amsbaugh Mark, Zhu Jay-Jiguang, Blanco Angel I, Riascos Roy F, Ballester Leomar Y, Tandon Nitin, Esquenazi Yoshua

Abstract excerpt

BACKGROUND: Glioblastoma isocitrate dehydrogenase (IDH)-wildtype (GBM) has been reclassified based on molecular and phenotypic features. Intratumoral hemorrhage is a phenotypic subtype with poorly understood molecular and clinical characteristics. We aimed to characterize the molecular profile and outcomes of hemorrhagic glioblastoma (hGBM) compared with non-hGBM. METHODS: A retrospective analysis of GBMs with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Follow-Up Studies

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 42635853
DOI: 10.1007/s11060-026-05749-3
PMCID: PMC13503418

Genes

KDR
KIT
PDGFRA
SETD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular features of intratumoral hemorrhage in glioblastoma isocitrate dehydrogenase-wildtype.PMID 42635853Read ↗

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsSemantic proximity Read ↗

Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.Semantic proximity Read ↗

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.Semantic proximity Read ↗

Molecularly diagnosed glioblastoma: clinical presentation and outcomes.Semantic proximity Read ↗

Glioblastoma: Changing concepts in the WHO CNS5 classification.Semantic proximity Read ↗

Distinguishing IDH-mutant astrocytomas from IDH-wildtype glioblastomas using qualitative and quantitative MRI features: a WHO CNS5 study.Semantic proximity Read ↗

Opinion & Special Article: Glioma Classification: How to Interpret Molecular Markers in a Diffuse Glioma Pathology Report.Semantic proximity Read ↗

Glioblastoma: Biology, Genetics, and BehaviorSemantic proximity Read ↗

Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?Semantic proximity Read ↗

An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatmentSemantic proximity Read ↗

Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.Semantic proximity Read ↗

Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.